2631 Hanover St
Palo Alto CA 94304

Management Team | Board of Directors

 

Corey S. Goodman, Ph.D., Chairman

Corey S. Goodman, Ph.D., serves as Chairman of the Oligasis Board of Directors. Dr. Goodman is cofounder and Managing Director of venBio.  Previously, he was president of Pfizer’s Biotherapeutics and Bioinnovation Center and a member of Pfizer’s executive leadership team, where he was charged with integrating innovative biologics technologies and protein engineering breakthroughs.  An elected member of the National Academy of Sciences, Dr. Goodman cofounded three biotech companies: Exelixis, Second Genome and Renovis, the latter for which he served as president and chief executive officer from a private to a public company until its acquisition by Evotec.  In addition to Oligasis, he currently chairs the Boards of iPierian, Limerick BioPharma and Second Genome.  Previously, a tenured professor at Stanford University and the University of California, Berkeley, Dr. Goodman is currently an adjunct professor at the University of California, San Francisco. He has won numerous scientific awards including the Alan T. Waterman Award from the National Science Board, the Gairdner International Award for Achievement in Medical Sciences, and the March-of-Dimes Prize in Developmental Biology. At U.C. Berkeley, he was a Howard Hughes Medical Institute Investigator, Evan Rauch Chair of Neuroscience, and cofounder of the Wills Neuroscience Institute.  Dr. Goodman earned his B.S. degree with distinction from Stanford University and his Ph.D. as an NSF fellow from U.C. Berkeley.  He was then a Helen Hay Whitney postdoctoral fellow at U.C. San Diego.